SEER Technology Published in Annals of Biomedical Engineering and to be Presented at IEEE International Ultrasonics Symposium

Charlottesville, VA – October 19, 2015 – HemoSonics, a medical device company developing and commercializing a point-of-care diagnostic platform to guide the management of critical bleeding, today announced that a paper detailing its novel SEER technology was published in the Annals of Biomedical Engineering. The paper, Sonic Estimation of Elasticity via Resonance: A New Method of Assessing Hemostasis, details the core technology behind the Quantra™, a point-of-care in vitro diagnostic platform that measures blood clot formation and breakdown and provides actionable information to guide the management of critical bleeding and clotting. SEER uses ultrasound to initiate and measure mechanical resonance in a clotting blood sample. The characteristics of this resonance are analyzed to precisely measure the evolving clot stiffness. SEER requires no moving parts and uses commodity electronics.

An abstract detailing HemoSonics’ SEER technology was also accepted for the IEEE International Ultrasonics Symposium. The conference will be held in Taipei, Taiwan, on October 21-24th, 2015.

Paper Citation

Corey, FS, and WF Walker. “Sonic Estimation of Elasticity Via Resonance: A New Method of Assessing Hemostasis.” Annals of biomedical engineering (2015)doi:10.1007/s10439-015-1460-y.

Abstract Details

Title: Sonic Estimation of Elasticity via Resonance (SEER): Initial Results from a New Method of Assessing Hemostasis
Authors: FS Corey, WF Walker
Session: 3I – MEL: Towards clinical application of elasticity imaging
Date: October 24, 2015, 10:30am – 10:45am